← Leaderboards
Michael F. Berger
Sloan-Kettering Inst Can Research
$6,644,929
Attributed
$9,318,330
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,318,330 · 4
By mechanism
R01$6,431,896 · 2
R25$1,499,162 · 1
P01$1,387,272 · 1
Top collaborators
- Ushma Neill5 shared
- Alexander Drilon4 shared
- Michelle Ginsberg4 shared
- Yaihara Myriam Fortis-Santiago1 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Alexander Drilon$4,847,187
- David B. Solit$21,393,031
- Elisa De Stanchina$4,011,743
- Hans-Guido Wendel$13,517,904
- Sarat Chandarlapaty$10,852,142
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsMemorial Sloan-Kettering Cancer CenterDiagnosisGenomicsOncologySamplingLearningInnovationBiologicalTumorResponseMutationCancer TherapyInsightGenomeFutureTargeted TreatmentGuidelinesBiological MarkersProspectiveFrequenciesDiagnosticClinical TrialsEnrollment
Grant awards (17)
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy$734,511
R01 · FY2025 · CA · contact PI
Core B: Molecular Pathology and Bioinformatics Core$698,153
P01 · FY2025 · CA · contact PI
MSK Computational Biology Summer Program$287,971
R25 · FY2025 · CA · contact PI
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy$697,771
R01 · FY2024 · CA · contact PI
Core B: Molecular Pathology and Bioinformatics Core$689,119
P01 · FY2024 · CA · contact PI
MSK Computational Biology Summer Program$320,371
R25 · FY2024 · CA · contact PI
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy$719,326
R01 · FY2023 · CA · contact PI
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing$697,766
R01 · FY2023 · CA · contact PI
MSK Computational Biology Summer Program$220,140
R25 · FY2023 · CA · contact PI
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy$734,122
R01 · FY2022 · CA · contact PI
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing$697,766
R01 · FY2022 · CA · contact PI
MSK Computational Biology Summer Program$220,140
R25 · FY2022 · CA · contact PI
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing$712,004
R01 · FY2021 · CA · contact PI
MSK Computational Biology Summer Program$220,140
R25 · FY2021 · CA · contact PI
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing$712,004
R01 · FY2020 · CA · contact PI
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing$726,626
R01 · FY2019 · CA · contact PI
MSK Computational Biology Summer Program$230,400
R25 · FY2019 · CA · contact PI